|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.230 USD | -1.63% |
|
+4.33% | -4.74% |
| 07-17 | Weave Launches Authorized Integration With Elation Health | CI |
| 07-17 | Weave Communications Integrates Patient Engagement Platform With Elation Health | MT |
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Revenues | 116M | 142M | 170M | 204M | 239M | ||
Total Revenues | 116M | 142M | 170M | 204M | 239M | ||
Cost of Goods Sold, Total | 49.37M | 53.28M | 54.38M | 58.43M | 66.72M | ||
Gross Profit | 66.5M | 88.84M | 116M | 146M | 172M | ||
Selling General & Admin Expenses, Total | 89.88M | 108M | 116M | 137M | 157M | ||
R&D Expenses | 27.01M | 30.71M | 34.04M | 40.23M | 44.35M | ||
Other Operating Expenses, Total | 117M | 139M | 150M | 177M | 201M | ||
Operating Income | -50.39M | -49.7M | -34.37M | -31.41M | -28.91M | ||
Interest Expense, Total | -1.18M | -1.44M | -1.92M | -1.52M | -1.7M | ||
Interest And Investment Income | - | - | 2.2M | 1.85M | 1.81M | ||
Net Interest Expenses | -1.18M | -1.44M | 273K | 328K | 111K | ||
Other Non Operating Income (Expenses) | -55K | 1.51M | 3.32M | 794K | 621K | ||
EBT, Excl. Unusual Items | -51.63M | -49.63M | -30.77M | -30.29M | -28.18M | ||
Merger & Related Restructuring Charges | - | - | - | - | -1.7M | ||
Gain (Loss) On Sale Of Investments | - | - | - | 2.13M | 902K | ||
EBT, Incl. Unusual Items | -51.63M | -49.63M | -30.77M | -28.16M | -28.98M | ||
Income Tax Expense | 60K | 104K | 260K | 189K | -924K | ||
Earnings From Continuing Operations | -51.69M | -49.74M | -31.03M | -28.35M | -28.05M | ||
Net Income to Company | -51.69M | -49.74M | -31.03M | -28.35M | -28.05M | ||
Net Income - (IS) | -51.69M | -49.74M | -31.03M | -28.35M | -28.05M | ||
Preferred Dividend and Other Adjustments | 1.96M | - | - | - | - | ||
Net Income to Common Incl Extra Items | -53.65M | -49.74M | -31.03M | -28.35M | -28.05M | ||
Net Income to Common Excl. Extra Items | -53.65M | -49.74M | -31.03M | -28.35M | -28.05M | ||
Per Share Items | |||||||
Net EPS - Basic | -2.6 | -0.76 | -0.46 | -0.4 | -0.37 | ||
Basic EPS - Continuing Operations | -2.6 | -0.76 | -0.46 | -0.4 | -0.37 | ||
Basic Weighted Average Shares Outstanding | 20.64M | 65.08M | 67.69M | 71.66M | 76.31M | ||
Net EPS - Diluted | -2.6 | -0.76 | -0.46 | -0.4 | -0.37 | ||
Diluted EPS - Continuing Operations | -2.6 | -0.76 | -0.46 | -0.4 | -0.37 | ||
Diluted Weighted Average Shares Outstanding | 20.64M | 65.08M | 67.69M | 71.66M | 76.31M | ||
Normalized Basic EPS | -1.56 | -0.48 | -0.28 | -0.26 | -0.23 | ||
Normalized Diluted EPS | -1.56 | -0.48 | -0.28 | -0.26 | -0.23 | ||
Supplemental Items | |||||||
EBITDA | -38.25M | -36.74M | -23.66M | -21.4M | -18.89M | ||
EBITA | -50.39M | -49.7M | -34.37M | -31.41M | -28.58M | ||
EBIT | -50.39M | -49.7M | -34.37M | -31.41M | -28.91M | ||
EBITDAR | -32.95M | -31.04M | -17.96M | -16.26M | -13.61M | ||
Effective Tax Rate - (Ratio) | -0.12 | -0.21 | -0.84 | -0.67 | 3.19 | ||
Current Domestic Taxes | - | - | 53K | 9K | 76K | ||
Current Foreign Taxes | - | 130K | 247K | 226K | 343K | ||
Total Current Taxes | - | 130K | 300K | 235K | 419K | ||
Deferred Domestic Taxes | - | - | - | - | -1.28M | ||
Deferred Foreign Taxes | - | -26K | -40K | -46K | -64K | ||
Total Deferred Taxes | - | -26K | -40K | -46K | -1.34M | ||
Normalized Net Income | -32.27M | -31.02M | -19.23M | -18.93M | -17.61M | ||
Interest on Long-Term Debt | 1.18M | 1.44M | 1.92M | 1.52M | 1.7M | ||
Supplemental Operating Expense Items | |||||||
Advertising Expense | 6.8M | 5.5M | 8.3M | 11.8M | 17.2M | ||
Selling and Marketing Expenses | 58.24M | 65.38M | 70.76M | 84.61M | 103M | ||
General and Administrative Expenses | 31.64M | 42.45M | 45.65M | 52.45M | 54.19M | ||
Research And Development Expense From Footnotes | 27.81M | 31.71M | 35.24M | 41.43M | 45.76M | ||
Net Rental Expense, Total | 5.3M | 5.7M | 5.71M | 5.13M | 5.28M | ||
Imputed Operating Lease Interest Expense | 2.31M | 1.33M | 1.32M | 1.08M | 1.33M | ||
Imputed Operating Lease Depreciation | 2.99M | 4.37M | 4.39M | 4.05M | 3.95M | ||
Stock-Based Comp., COGS (Total) | 526K | 723K | 971K | 1.01M | 894K | ||
Stock-Based Comp., R&D Exp. (Total) | 3.54M | 4.58M | 5.59M | 8.37M | 8.81M | ||
Stock-Based Comp., S&M Exp. (Total) | 1.96M | 3.44M | 4.23M | 6.58M | 7.51M | ||
Stock-Based Comp., G&A Exp. (Total) | 8.06M | 10.02M | 12.03M | 16.25M | 14.92M | ||
Total Stock-Based Compensation | 14.09M | 18.75M | 22.82M | 32.22M | 32.13M |
- Stock Market
- Stocks
- WEAV Stock
- Financials Weave Communications, Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















